An article in Pharmaceutical Commerce examines how artificial intelligence efficiency gains in life sciences may not deliver transformative results without broader strategic implementation. The piece argues that simply accelerating individual tasks through AI technologies is insufficient to fundamentally reshape the pharmaceutical and life sciences industries without addressing systemic challenges and integration approaches.